GEODE CAPITAL MANAGEMENT, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 86 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$242,000
-8.0%
1,162,072
+7.8%
0.00%
Q2 2022$263,000
-13.5%
1,077,599
+0.9%
0.00%
Q1 2022$304,000
-44.6%
1,068,118
+8.9%
0.00%
Q4 2021$549,000
-45.3%
980,612
-0.5%
0.00%
Q3 2021$1,004,000
-30.8%
985,253
-6.2%
0.00%
Q2 2021$1,450,000
-49.0%
1,050,806
-37.1%
0.00%
Q1 2021$2,841,000
+87.0%
1,671,558
+36.4%
0.00%
Q4 2020$1,519,000
-19.3%
1,225,684
-7.6%
0.00%
Q3 2020$1,883,000
+24.3%
1,326,504
+5.9%
0.00%
Q2 2020$1,515,000
+11.3%
1,252,107
+8.6%
0.00%
Q1 2020$1,361,000
-70.4%
1,153,393
-47.1%
0.00%
Q4 2019$4,602,000
+108.2%
2,181,368
+117.1%
0.00%
-100.0%
Q3 2019$2,210,000
-11.7%
1,004,597
+1.5%
0.00%0.0%
Q2 2019$2,504,000
+16.0%
990,044
+59.5%
0.00%0.0%
Q1 2019$2,159,000
-2.2%
620,557
-35.1%
0.00%
Q4 2018$2,208,000
+65.8%
956,698
+176.4%
0.00%
Q3 2018$1,332,000
+58.0%
346,097
+38.4%
0.00%
Q2 2018$843,000
+86.1%
250,005
+15.8%
0.00%
Q1 2018$453,000
+3.7%
215,8340.0%0.00%
Q4 2017$437,000
-55.9%
215,8340.0%0.00%
Q3 2017$992,000
+163.8%
215,834
+23.1%
0.00%
Q2 2017$376,000
-47.2%
175,262
-22.5%
0.00%
Q1 2017$712,000
+24.7%
226,156
+2.9%
0.00%
Q4 2016$571,000
-30.9%
219,833
+3.4%
0.00%
Q3 2016$826,000
+49.6%
212,568
+3.5%
0.00%
Q2 2016$552,000
+5.1%
205,291
+20.2%
0.00%
Q1 2016$525,000
-17.5%
170,734
+3.3%
0.00%
Q4 2015$636,000
+54.0%
165,307
+22.0%
0.00%
Q3 2015$413,000
-24.4%
135,544
+5.1%
0.00%
Q2 2015$546,000
-5.7%
128,938
-14.1%
0.00%
Q1 2015$579,000
-41.4%
150,177
+2.2%
0.00%
-100.0%
Q4 2014$988,000
+33.5%
146,902
+8.9%
0.00%
Q3 2014$740,000
-42.3%
134,841
+7.7%
0.00%
-100.0%
Q2 2014$1,283,000
-13.4%
125,216
+1.4%
0.00%0.0%
Q1 2014$1,482,000
+21.7%
123,436
+14.6%
0.00%0.0%
Q4 2013$1,218,000
+7.4%
107,726
+2.3%
0.00%0.0%
Q3 2013$1,134,000
+59.0%
105,273
+36.9%
0.00%0.0%
Q2 2013$713,00076,9010.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders